Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1974 Dec;18(4):519–528.

The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis

R J Mangi, J M Dwyer, F S Kantor
PMCID: PMC1538005  PMID: 4619882

Abstract

The role of humoral inhibitors of lymphocyte functions was evaluated in subjects with sarcoidosis. A reproducible system was developed to evaluate the capacity of human plasma samples to support lymphocyte responses in vitro to PHA and to Candida albicans antigen.

There was an unacceptable ten-fold variation in lymphocyte response to PHA among cultures that contained different individual samples of normal plasma. However, when any three normal plasma samples were pooled, the variation was reduced to two-fold. Seven out of twenty-five individual normal plasma samples tested did not support stimulation as well as a pool of plasma.

In contrast, autologous plasma sustained normal lymphocyte stimulation as well as or better than pooled homologous plasma. We tested the ability of plasma from subjects with sarcoidosis to support the stimulation of autologous lymphocytes by PHA and antigen, and compared this response to that obtained when the same lymphocytes were stimulated in cultures that contained pooled normal plasma. Lymphocytes of thirteen out of twenty-six subjects with sarcoidosis did not respond to in vitro stimulation in their own plasma as well as they did when cultured in the pooled plasma of normal subjects. Plasma of fourteen out of twenty-five patients with sarcoidosis caused a significant decrease in the response of normal lymphocytes to PHA, even when added to optimal concentration of pooled normal plasma. We conclude that the plasma of patients with sarcoidosis contains an inhibitor of lymphocyte stimulation.

Full text

PDF
519

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belcher R. W., Carney J. F., Nankervis G. A. Effect of sera from patients with sarcoidosis on in vitro lymphocyte response. Int Arch Allergy Appl Immunol. 1974;46(2):183–190. doi: 10.1159/000231122. [DOI] [PubMed] [Google Scholar]
  2. Bredt A. B., Mardiney M. R., Jr Reactivity of human lymphocytes to autologous and homologous serum. J Immunol. 1969 Jun;102(6):1526–1529. [PubMed] [Google Scholar]
  3. Buckley C. E., 3rd, Nagaya H., Sieker H. O. Altered immunologic activity in sarcoidosis. Ann Intern Med. 1966 Mar;64(3):508–520. doi: 10.7326/0003-4819-64-3-508. [DOI] [PubMed] [Google Scholar]
  4. Bullock W. E., Jr, Fasal P. Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response. J Immunol. 1971 Apr;106(4):888–899. [PubMed] [Google Scholar]
  5. CITRON K. M., SCADDING J. G. The effect of cortisone upon the reaction of the skin to tuberculin in tuberculosis and in sarcoidosis. Q J Med. 1957 Jul;26(103):277–289. [PubMed] [Google Scholar]
  6. Canales L., Middlemas R. O., 3rd, Louro J. M., South M. A. Immunological observations in chronic mucocutaneous candidiasis. Lancet. 1969 Sep 13;2(7620):567–571. doi: 10.1016/s0140-6736(69)90264-5. [DOI] [PubMed] [Google Scholar]
  7. Chase P. S. The effects of human serum fractions on phytohemagglutinin- and concanavalin A-stimulated human lymphocyte cultures. Cell Immunol. 1972 Dec;5(4):544–554. doi: 10.1016/0008-8749(72)90104-9. [DOI] [PubMed] [Google Scholar]
  8. Chusid E. L., Shah R., Siltzbach L. E. Tuberculin tests during the course of sarcoidosis in 350 patients. Am Rev Respir Dis. 1971 Jul;104(1):13–21. doi: 10.1164/arrd.1971.104.1.13. [DOI] [PubMed] [Google Scholar]
  9. Cooperband S. R., Davis R. C., Schmid K., Mannick J. A. Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA). Transplant Proc. 1969 Mar;1(1):516–523. [PubMed] [Google Scholar]
  10. Dwyer J. M., Kantor F. S. Regulation of delayed hypersensitivity. Failure to transfer delayed hypersensitivity to desensitized guinea pigs. J Exp Med. 1973 Jan 1;137(1):32–41. doi: 10.1084/jem.137.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dwyer J., Lazarus L., Hickie J. B. A study of cortisol metabolism in patients with chronic asthma. Australas Ann Med. 1967 Nov;16(4):297–304. doi: 10.1111/imj.1967.16.4.297. [DOI] [PubMed] [Google Scholar]
  12. EPSTEIN W. L., MAYOCK R. L. Induction of allergic contact dermatitis in patients with sarcoidosis. Proc Soc Exp Biol Med. 1957 Dec;96(3):786–787. doi: 10.3181/00379727-96-23608. [DOI] [PubMed] [Google Scholar]
  13. Girard J. P., Poupon M. F., Press P. Culture of peripheral blood lymphocytes from sarcoidosis; response to mitogenic factor. Int Arch Allergy Appl Immunol. 1971;41(4):604–619. doi: 10.1159/000230553. [DOI] [PubMed] [Google Scholar]
  14. HIRSCHHORN K., SCHREIBMAN R. R., BACH F. H., SILTZBACH L. E. IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES. Lancet. 1964 Oct 17;2(7364):842–843. doi: 10.1016/s0140-6736(64)90691-9. [DOI] [PubMed] [Google Scholar]
  15. Heilman D. H., McFarland W. Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors. Int Arch Allergy Appl Immunol. 1966;30(1):58–66. doi: 10.1159/000229793. [DOI] [PubMed] [Google Scholar]
  16. ISRAEL H. L., SONES M., STEIN S. C., ARONSON J. D. BCG vaccination in sarcoidosis. Am Rev Tuberc. 1950 Oct;62(4):408–417. doi: 10.1164/art.1950.62.4.408. [DOI] [PubMed] [Google Scholar]
  17. Israel H. L., Sones M. Sarcoidosis, tuberculosis, and tuberculin anergy. A prospective study. Am Rev Respir Dis. 1966 Dec;94(6):887–895. doi: 10.1164/arrd.1966.94.6.887. [DOI] [PubMed] [Google Scholar]
  18. JAMES D. G., PEPYS J. Tuberculin in aqueous and oily solutions; skin-test reactions in normal subjects and in patients with sarcoidosis. Lancet. 1956 May 5;270(6923):602–604. doi: 10.1016/s0140-6736(56)90647-x. [DOI] [PubMed] [Google Scholar]
  19. Knowles M., Hughes D., Caspary E. A., Field E. J. Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet. 1968 Dec 7;2(7580):1207–1209. doi: 10.1016/s0140-6736(68)91691-7. [DOI] [PubMed] [Google Scholar]
  20. Levene G. M., Turk J. L., Wright D. J., Grimble A. G. Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis. Lancet. 1969 Aug 2;2(7614):246–247. doi: 10.1016/s0140-6736(69)90010-5. [DOI] [PubMed] [Google Scholar]
  21. Mangi R. J., Dwyer J. M., Gee B., Kantor F. S. The immunological competence of subjects with sarcoidosis. Clin Exp Immunol. 1974 Dec;18(4):505–517. [PMC free article] [PubMed] [Google Scholar]
  22. McFarlin D. E., Oppenheim J. J. Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor. J Immunol. 1969 Dec;103(6):1212–1222. [PubMed] [Google Scholar]
  23. PYKE D. A., SCADDING J. G. Effect of cortisone upon skin sensitivity to tuberculin in sarcoidosis. Br Med J. 1952 Nov 22;2(4794):1126–1128. doi: 10.1136/bmj.2.4794.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Paronetto F., Popper H. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med. 1970 Aug 6;283(6):277–280. doi: 10.1056/NEJM197008062830602. [DOI] [PubMed] [Google Scholar]
  25. SNYDER G. B. THE FATE OF SKIN HOMOGRAFTS IN PATIENTS WITH SARCOIDOSIS. Bull Johns Hopkins Hosp. 1964 Aug;115:81–91. [PubMed] [Google Scholar]
  26. Steward A. M. Tuberculin reaction in cancer patients, "Mantoux release," and lymphosuppressive-stimulatory factors. J Natl Cancer Inst. 1973 Mar;50(3):625–632. doi: 10.1093/jnci/50.3.625. [DOI] [PubMed] [Google Scholar]
  27. Topilsky M., Siltzbach L. E., Williams M., Glade P. R. Lymphocyte response in sarcoidosis. Lancet. 1972 Jan 15;1(7742):117–120. doi: 10.1016/s0140-6736(72)90680-0. [DOI] [PubMed] [Google Scholar]
  28. Trubowitz S., Masek B., Del Rosario A. Lymphocyte response to phytohemagglutinin in Hodgkin's disease, lymphatic leukemia and lymphosarcoma. Cancer. 1966 Dec;19(12):2019–2023. doi: 10.1002/1097-0142(196612)19:12<2019::aid-cncr2820191228>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  29. URBACH F., SONES M., ISRAEL H. L. Passive transfer of tuberculin sensitivity to patients with sarcoidosis. N Engl J Med. 1952 Nov 30;247(21):794–797. doi: 10.1056/NEJM195211202472103. [DOI] [PubMed] [Google Scholar]
  30. Whittaker M. G., Rees K., Clark C. G. Reduced lymphocyte transformation in breast cancer. Lancet. 1971 May 1;1(7705):892–893. doi: 10.1016/s0140-6736(71)92448-2. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES